| 0 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
2 |
0.0011 |
| 1 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
2 |
0.0005 |
| 2 |
Human Immunoglobulin G [EPC] |
6 |
0.0003 |
| 3 |
Antimetabolite Immunosuppressant [EPC] |
6 |
0.0003 |
| 4 |
Autologous Cellular Immunotherapy [EPC] |
1 |
0.0002 |
| 5 |
Penem Antibacterial [EPC] |
3 |
0.0001 |
| 6 |
Glycopeptide Antibacterial [EPC] |
5 |
0.0001 |
| 7 |
Interleukin-6 Receptor Antagonist [EPC] |
10 |
0.0001 |
| 8 |
Oxazolidinone Antibacterial [EPC] |
2 |
0.0001 |
| 9 |
Purine Antimetabolite [EPC] |
6 |
0.0001 |
| 10 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Folate Analog Metabolic Inhibitor [EPC] |
15 |
0.0000 |
| 12 |
Alkylating Drug [EPC] |
7 |
0.0000 |
| 13 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 14 |
Azole Antifungal [EPC] |
3 |
0.0000 |
| 15 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 16 |
Factor Xa Inhibitor [EPC] |
5 |
0.0000 |
| 17 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 18 |
Antidote [EPC] |
1 |
0.0000 |
| 19 |
Tumor Necrosis Factor Blocker [EPC] |
14 |
0.0000 |
| 20 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Corticosteroid [EPC] |
17 |
0.0000 |
| 22 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 23 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 24 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 25 |
Kinase Inhibitor [EPC] |
5 |
0.0000 |
| 26 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 27 |
Prostacycline Vasodilator [EPC] |
1 |
0.0000 |
| 28 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
7 |
0.0000 |
| 30 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 32 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 33 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |